Colorectal cancer treatment study in real-world care
Part of Cancer, Digestive system clinical trials.
This study looks at how well treatments work for colorectal cancer in everyday medical practice. It may help doctors understand which therapies are most effective for people like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years old or older.
- You have been diagnosed with colorectal cancer.
- You started your anti-cancer treatment between January 1, 2025 and December 31, 2027.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study looks at how colorectal cancer patients are treated and their outcomes at a major medical center in Rome. It helps doctors understand what approaches work best for patients like you.
This study builds a database of people with colorectal cancer. It may help doctors learn from real-world information to improve future care.
This study follows patients with colorectal cancer over time to understand the disease better. It does not test a new treatment, but collects information from medical records and visits.
This study enrolls people newly diagnosed with colon or rectal cancer to learn about their care and outcomes. You might be able to join if you meet the age, language, and consent requirements.
This retrospective study uses existing colorectal cancer imaging and/or preserved tissue samples to support more precise (personalized) research. It may help researchers better understand colorectal cancer over time, but it does not involve new treatment.
This study is collecting information from people with newly diagnosed colon or rectal cancer, to better understand the disease and support future research. It may help you and others by improving how colorectal cancer is studied and potentially treated over time.
Hear when a new Survival , Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.